Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study

<div>The median OS (months) of each group of patients in any periods are displayed using line charts: (a) immunocompromised patients with DLBCL, (b) immunocompromised patients with non-DLBCL, (c) immunocompetent patients with DLBCL, and (d) immunocompetent patients with non-DLBCL</div>

Disease Markers

fig5

Figure 5

Figure 5: Prognostic Factors and Survival in Primary Central Nervous System Lymphoma: A Population-Based Study 